7Baggers

agilon health, inc.
(NYSE:AGL) 

AGL stock logo

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in L...

Founded: 2016
Sector: Healthcare
Industry: Medical Care Facilities
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                        
      revenues:
    		                    
      medical services revenue
    		1,566,986,000 1,432,437,000 1,392,039,000 1,529,879,000 1,519,244,000 1,447,697,000 1,479,579,000 1,601,195,000 813,344,000 1,212,132,000 1,147,044,000 1,134,830,000 688,855,000 693,934,000 669,184,000 652,423,000 461,999,000 457,646,000 497,678,000 412,412,000 
      other operating revenue
    		2,505,000 2,884,000 2,943,000 2,903,000 3,242,000 3,235,000 3,179,000 3,159,000 2,160,000 3,528,000 2,008,000 1,317,000 919,000 924,000 950,000 1,022,000 887,000 967,000 1,278,000 692,000 
      total revenues
    		1,569,491,000 1,435,321,000 1,394,982,000 1,532,782,000 1,522,486,000 1,450,932,000 1,482,758,000 1,604,354,000 815,504,000 1,215,660,000 1,149,052,000 1,136,147,000 689,774,000 694,858,000 670,134,000 653,445,000 462,886,000 458,613,000 498,956,000 413,104,000 
      yoy
    		3.09% -1.08% -5.92% -4.46% 86.69% 19.35% 29.04% 41.21% 18.23% 74.95% 71.47% 73.87% 49.02% 51.51% 34.31% 58.18%     
      qoq
    		9.35% 2.89% -8.99% 0.68% 4.93% -2.15% -7.58% 96.73% -32.92% 5.80% 1.14% 64.71% -0.73% 3.69% 2.55% 41.17% 0.93% -8.09% 20.78%  
      expenses:
    		                    
      medical services expense
    		1,641,315,000 1,489,479,000 1,445,245,000 1,401,867,000 1,518,678,000 1,505,950,000 1,374,060,000 1,443,842,000 922,702,000 1,104,396,000 1,008,734,000 972,827,000 628,163,000 618,287,000 587,140,000 566,208,000 430,620,000 414,202,000 442,483,000 360,354,000 
      other medical expenses
    		18,846,000 13,488,000 2,164,000 80,193,000 42,063,000 9,149,000 76,523,000 85,424,000 -11,902,000 80,787,000 83,125,000 86,024,000 51,615,000 50,659,000 49,080,000 44,773,000 22,678,000 29,454,000 33,694,000 23,661,000 
      general and administrative
    		60,101,000 56,198,000 56,281,000 65,956,000 59,755,000 63,123,000 69,612,000 76,422,000 63,277,000 74,138,000 81,499,000 66,846,000 75,207,000 51,980,000 51,924,000 39,834,000 341,820,000 34,683,000 43,013,000 37,777,000 
      depreciation and amortization
    		6,969,000 7,430,000 7,319,000 6,876,000 6,494,000 6,218,000 5,907,000 5,844,000 1,029,000 5,310,000 5,515,000 4,189,000 3,907,000 3,450,000 3,042,000 3,373,000 3,621,000 3,915,000 3,581,000 3,427,000 
      total expenses
    		1,763,316,000 1,566,595,000 1,511,009,000 1,554,892,000 1,630,586,000 1,584,440,000 1,526,102,000 1,611,532,000 975,106,000 1,264,631,000 1,178,873,000 1,129,886,000 758,892,000 724,376,000 691,186,000 654,188,000 510,759,000 494,214,000 797,319,000 425,219,000 
      income from operations
    		-193,825,000 -131,274,000 -116,027,000 -22,110,000 -108,100,000 -133,508,000 -43,344,000 -7,178,000 -159,602,000 -48,971,000 -29,821,000 6,261,000 -69,118,000 -29,518,000 -21,052,000 -743,000 -47,873,000 -35,601,000 -298,363,000 -12,115,000 
      yoy
    		79.30% -1.67% 167.69% 208.02% -32.27% 172.63% 45.35% -214.65% 130.91% 65.90% 41.65% -942.66% 44.38% -17.09% -92.94% -93.87%     
      qoq
    		47.65% 13.14% 424.77% -79.55% -19.03% 208.02% 503.85% -95.50% 225.91% 64.22% -576.30% -109.06% 134.16% 40.21% 2733.38% -98.45% 34.47% -88.07% 2362.76%  
      operating margin %
    		-12.35% -9.15% -8.32% -1.44% -7.10% -9.20% -2.92% -0.45% -19.57% -4.03% -2.60% 0.55% -10.02% -4.25% -3.14% -0.11% -10.34% -7.76% -59.80% -2.93% 
      other income:
    		                    
      income from equity method investments
    		-33,052,000 13,133,000 5,412,000 12,672,000 -2,694,000 2,047,000 9,955,000 5,684,000 -8,018,000 14,659,000           
      other income
    		41,035,000 9,441,000 7,879,000 9,261,000 7,695,000 16,061,000 4,841,000 5,892,000 6,839,000 5,690,000 15,687,000 9,472,000 14,885,000 574,000 6,997,000 2,269,000 -8,534,000 -269,000 2,967,000 1,336,000 
      interest expense
    		-1,716,000 -1,838,000 -1,572,000 -1,515,000 -1,574,000 -1,622,000 -1,697,000 -1,284,000 -1,886,000 -1,651,000 -1,588,000 -1,533,000 -1,709,000 -1,000,000 -945,000 -871,000 -840,000 -867,000 -1,498,000 -2,941,000 
      income before income taxes
    		-187,558,000 -110,538,000 -104,308,000 -1,692,000 -104,673,000 -117,022,000 -30,245,000 3,114,000 -162,667,000 -30,273,000 -15,722,000 14,200,000 -55,942,000 -29,944,000 -20,458,000 655,000 -57,247,000 -36,737,000 -296,894,000 -13,720,000 
      income tax benefit
    		-1,324,000 331,000 -62,000 -196,000 -1,757,000 590,000 -417,000 133,000 -267,000 -1,210,000 -1,073,000 1,759,000 -572,000 -559,000 -580,000 71,000 -179,000 -256,000 -435,000 -16,000 
      income from continuing operations
    		-188,882,000 -110,207,000 -104,370,000 -1,888,000 -106,430,000 -116,432,000 -30,662,000 3,247,000 -162,934,000 -31,483,000 -16,795,000 15,959,000 -56,514,000 -30,503,000 -21,038,000 726,000 -57,426,000 -36,993,000 -297,329,000 -13,736,000 
      discontinued operations:
    		                    
      income before gain on sales
    		    -425,250 -1,183,000  -518,000             
      adjustments on sale of assets
    		3,500,000   14,000,000                 
      total discontinued operations
    		   14,000,000 640,000 -1,183,000  -9,281,000     -35,000 -236,000 307,000 429,000 689,000 1,035,000 -1,612,000 -1,415,000 
      net income
    		-188,882,000 -110,207,000 -104,370,000 12,112,000 -105,790,000 -117,615,000 -30,662,000 -6,034,000 -230,484,000 -31,483,000 -16,795,000 15,959,000 -56,549,000 -30,739,000 -20,731,000 1,155,000 -56,737,000 -35,958,000 -298,941,000 -15,151,000 
      yoy
    		78.54% -6.30% 240.39% -300.73% -54.10% 273.58% 82.57% -137.81% 307.58% 2.42% -18.99% 1281.73% -0.33% -14.51% -93.07% -107.62%     
      qoq
    		71.39% 5.59% -961.71% -111.45% -10.05% 283.59% 408.15% -97.38% 632.09% 87.45% -205.24% -128.22% 83.96% 48.28% -1894.89% -102.04% 57.79% -87.97% 1873.08%  
      net income margin %
    		-12.03% -7.68% -7.48% 0.79% -6.95% -8.11% -2.07% -0.38% -28.26% -2.59% -1.46% 1.40% -8.20% -4.42% -3.09% 0.18% -12.26% -7.84% -59.91% -3.67% 
      noncontrolling interests’ share in (earnings) loss
    		      -20,000 -30,000 51,000 47,000 46,000 63,000 83,000 71,000 82,000 75,000 16,000 115,000 96,000  
      net income attributable to common shares
    		-188,882,000 -110,207,000 -104,370,000 12,112,000 -105,790,000 -117,615,000 -30,682,000 -6,064,000 -230,433,000 -31,436,000 -16,749,000 16,022,000 -56,466,000 -30,668,000 -20,649,000 1,230,000 -56,721,000 -35,843,000 -298,845,000 -15,078,000 
      net income per common share, basic and diluted
    		                    
      continuing operations
    		-460 -270 -250  -260 -290 -70 10 -400 -80 -40 40 -140 -70 -50  -140 -90 -790 -40 
      discontinued operations
    		   30 10   -20         -2.5   -10 
      weighted-average shares outstanding
    		                    
      basic and diluted
    		 414,465,000 413,836,000                  
      weighted-average shares outstanding – basic and diluted
    		   412,936,000                 
      gain on sales of assets
    		       -8,763,000             
      weighted-average shares outstanding
    		                    
      basic
    		     411,591,000 411,271,000 408,938,000  405,787,000 410,338,000 413,136,000    401,964,000     
      diluted
    		     411,591,000 411,271,000 413,437,000  405,787,000 410,338,000 426,586,000    424,065,000     
      gain on lease terminations
    		              -5,458,000      
      weighted-average shares outstanding, basic and diluted
    		413,969,000    410,966,000    408,917,000    408,154,000 411,065,000 407,339,000  372,931,000 391,229,000 377,445,000 325,659,000 
      stock-based compensation expense
    		                71,995,000 11,960,000 274,548,000  
      noncontrolling interests’ share in earnings
    		                   73,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                          
        assets
      		                    
        current assets:
      		                    
        cash and cash equivalents
      		173,713,000 171,684,000 171,416,000 136,941,000 188,231,000 148,161,000 109,490,000 111,706,000 107,570,000 168,339,000 190,981,000 394,190,000 497,070,000 551,287,000 668,574,000 1,021,754,000 1,040,039,000 1,081,601,000 1,109,372,000 105,289,000 
        restricted cash and equivalents
      		   1,682,000 5,629,000 5,629,000 6,846,000 6,844,000 6,759,000 10,204,000 10,204,000 10,204,000 10,610,000 13,192,000 15,085,000 14,470,000 14,781,000 14,302,000 16,343,000 14,202,000 
        marketable securities
      		111,429,000 139,170,000 155,585,000 230,143,000 211,737,000 244,766,000 291,622,000 307,359,000 380,773,000 395,878,000 389,046,000 422,492,000 411,901,000 407,993,000 285,590,000      
        receivables
      		673,793,000 947,157,000 1,047,164,000 1,239,603,000 1,017,040,000 1,368,349,000 1,437,040,000 1,571,143,000 942,461,000 1,345,711,000 1,417,052,000 1,004,856,000 497,574,000 637,731,000 607,632,000 571,869,000 293,407,000 342,500,000 338,359,000 288,827,000 
        prepaid expenses and other current assets
      		137,762,000 80,017,000 78,495,000 42,353,000 35,137,000 44,854,000 39,012,000 39,757,000 42,513,000 36,512,000 37,560,000 44,697,000 34,119,000 24,067,000 24,528,000 19,847,000 18,968,000 14,463,000 15,740,000 9,314,000 
        total current assets
      		1,096,697,000 1,338,028,000 1,452,660,000 1,650,722,000 1,457,774,000 1,811,759,000 1,884,010,000 2,036,809,000 1,480,076,000 1,956,644,000 2,044,843,000 1,876,439,000 1,451,274,000 1,634,270,000 1,601,409,000 1,627,940,000 1,367,195,000 1,452,866,000 1,479,814,000 417,632,000 
        property, equipment, and capitalized software
      		25,417,000                    
        intangible assets
      		65,725,000 75,254,000 65,595,000 68,187,000 72,771,000 73,412,000 74,821,000 72,076,000 63,769,000 92,657,000 94,185,000 92,712,000 67,680,000 60,602,000 62,505,000 53,709,000 55,398,000 58,147,000 58,663,000 61,609,000 
        goodwill
      		 24,133,000 24,133,000 24,133,000 24,133,000 24,133,000 24,133,000 24,133,000 24,133,000 62,387,000 62,140,000 62,140,000 41,540,000 41,540,000 41,540,000 41,540,000 41,540,000 41,540,000 41,540,000 41,540,000 
        other assets
      		83,451,000 132,682,000 143,097,000 161,731,000 151,136,000 153,913,000 152,530,000 155,906,000 145,312,000 140,184,000 127,346,000 116,846,000 116,924,000 116,083,000 119,260,000 119,496,000 112,958,000 126,105,000 117,128,000 47,259,000 
        total assets
      		1,271,290,000 1,596,245,000 1,712,895,000 1,932,861,000 1,733,983,000 2,091,411,000 2,163,315,000 2,316,463,000 1,740,866,000 2,278,075,000 2,352,921,000 2,170,269,000 1,697,468,000 1,870,435,000 1,840,522,000 1,855,211,000 1,586,252,000 1,685,120,000 1,701,734,000 574,038,000 
        liabilities and stockholders’ equity
      		                    
        current liabilities:
      		                    
        medical claims and related payables
      		929,770,000 1,059,398,000 1,042,257,000 1,113,084,000 931,664,000 1,190,665,000 1,097,664,000 1,266,651,000 737,724,000 1,005,762,000 1,099,533,000 745,557,000 346,727,000 490,840,000 458,038,000 472,323,000 239,014,000 288,121,000 300,981,000 276,984,000 
        accounts payable and accrued expenses
      		127,477,000 145,517,000 171,886,000 226,693,000   280,899,000 252,497,000 233,182,000 290,563,000 257,819,000 222,052,000 183,364,000 162,386,000 142,048,000 133,138,000 112,946,000 129,660,000 107,599,000 95,122,000 
        current portion of long-term debt
      		19,238,000      8,750,000 7,500,000 6,250,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 3,750,000  
        total current liabilities
      		1,076,485,000 1,239,881,000 1,249,088,000 1,374,701,000 1,152,006,000 1,409,157,000 1,387,313,000 1,526,648,000 977,156,000 1,301,325,000 1,362,352,000 972,609,000 535,091,000 658,226,000 605,086,000 610,461,000 356,960,000 422,781,000 412,330,000 372,106,000 
        long-term debt
      		15,750,000    34,904,000 34,884,000 27,360,000 29,834,000 32,308,000 34,780,000 36,017,000 37,249,000 38,482,000 39,713,000 40,943,000 42,172,000 43,401,000 44,628,000 45,862,000 99,412,000 
        other liabilities
      		52,321,000 50,287,000 54,878,000 57,906,000 76,121,000 72,498,000 72,775,000 71,495,000 70,381,000 70,370,000 75,106,000 78,571,000 83,286,000 87,207,000 91,122,000 91,101,000 94,295,000 90,272,000 93,264,000 91,264,000 
        total liabilities
      		1,144,556,000 1,290,168,000 1,303,966,000 1,432,607,000 1,263,031,000 1,516,539,000 1,487,448,000 1,627,977,000 1,079,845,000 1,406,475,000 1,473,475,000 1,088,429,000 656,859,000 785,146,000 737,151,000 743,734,000 494,656,000 557,681,000 551,456,000 562,782,000 
        commitments and contingencies
      		                    
        stockholders' equity
      		                    
        common stock
      		4,147,000 4,146,000 4,143,000 4,130,000 4,122,000 4,120,000 4,114,000 4,108,000 4,064,000 4,060,000 4,054,000 4,145,000 4,124,000 4,117,000 4,082,000 4,057,000 4,001,000 3,915,000 3,909,000 2,494,000 
        additional paid-in capital
      		2,099,995,000 2,090,493,000 2,083,234,000 2,070,446,000 2,053,895,000 2,051,638,000 2,038,540,000 2,020,803,000 1,986,899,000 1,970,930,000 1,947,438,000 2,130,126,000 2,106,886,000 2,094,562,000 2,076,329,000 2,064,242,000 2,045,572,000 2,024,764,000 2,011,651,000 265,603,000 
        accumulated deficit
      		-1,978,324,000 -1,789,442,000 -1,679,235,000 -1,574,865,000 -1,586,977,000 -1,481,187,000 -1,363,572,000 -1,332,890,000 -1,326,826,000 -1,096,393,000 -1,064,957,000 -1,048,208,000 -1,064,230,000 -1,007,764,000 -977,096,000 -956,447,000 -957,677,000 -900,956,000 -865,113,000 -566,268,000 
        accumulated other comprehensive income
      		916,000 880,000 787,000 543,000 -88,000 301,000 -2,447,000 -2,747,000 -2,298,000 -6,230,000 -6,369,000 -3,549,000 -5,560,000 -5,098,000 513,000      
        total stockholders’ equity
      		126,734,000 306,077,000 408,929,000 500,254,000 470,952,000 574,872,000 675,867,000 688,486,000 661,021,000 871,600,000 879,446,000 1,081,840,000 1,040,609,000 1,085,289,000 1,103,371,000 1,111,477,000 1,091,596,000 1,127,439,000 1,150,278,000 -298,244,000 
        total liabilities and stockholders’ equity
      		1,271,290,000 1,596,245,000 1,712,895,000 1,932,861,000 1,733,983,000 2,091,411,000 2,163,315,000 2,316,463,000 1,740,866,000 2,278,075,000 2,352,921,000 2,170,269,000 1,697,468,000 1,870,435,000 1,840,522,000 1,855,211,000     
        property and equipment
      		 26,148,000 27,410,000 28,088,000 28,169,000 28,194,000 27,821,000 27,539,000 27,576,000 26,203,000 24,407,000 22,132,000 20,050,000 17,940,000 15,808,000 12,526,000 9,161,000 6,462,000 4,589,000 4,799,000 
        current debt
      		 34,966,000 34,945,000 34,924,000                 
        accounts payable, accrued expenses and other
      		    220,342,000 218,492,000               
        total agilon health, inc. stockholders' equity
      		    470,952,000 574,872,000 676,635,000 689,274,000 661,839,000 872,367,000 880,166,000 1,082,514,000 1,041,220,000 1,085,817,000 1,103,828,000 1,111,852,000 1,091,896,000 1,127,723,000 1,150,447,000 -298,171,000 
        noncontrolling interests
      		      -768,000 -788,000 -818,000 -767,000 -720,000 -674,000 -611,000 -528,000 -457,000 -375,000 -300,000 -284,000 -169,000 -73,000 
        current assets of discontinued operations
      		                    
        non-current assets of discontinued operations
      		                    
        current liabilities of discontinued operations
      		                    
        non-current liabilities of discontinued operations
      		                    
        current assets held for sale and discontinued operations
      		                    
        liabilities, contingently redeemable common stock and stockholders’ equity
      		                    
        current liabilities held for sale and discontinued operations
      		                    
        contingently redeemable common stock, 0.01 par value: 76,201 shares issued and outstanding at december 31, 2020
      		                    
        total liabilities, contingently redeemable common stock and stockholders’ equity
      		                1,586,252,000 1,685,120,000 1,701,734,000 574,038,000 
        mezzanine equity:
      		                    
        non-current assets held for sale
      		                   1,199,000 
        contingently redeemable common stock, 0.01 par value: 76,201 shares issued and outstanding
      		                   309,500,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
                            
          cash flows from operating activities:
        		                    
          net income
        		-188,882,000 -110,207,000 -104,370,000 12,112,000 -105,790,000 -117,615,000 -30,662,000 -6,034,000 -230,484,000 -31,483,000 -16,795,000 15,959,000 -56,549,000 -30,739,000 -20,731,000 1,155,000 -56,737,000 -35,958,000 -298,941,000 -15,151,000 
          adjustments to reconcile net income to net cash from operating activities:
        		                    
          depreciation and amortization
        		6,969,000 7,430,000 7,319,000 6,876,000 6,494,000 6,218,000 5,907,000 5,844,000 5,147,000 5,310,000 5,515,000 4,189,000 3,907,000 3,450,000 3,042,000 3,373,000 3,638,000 3,937,000 3,614,000 3,481,000 
          stock-based compensation expense
        		9,520,000 7,498,000 15,381,000 16,720,000 2,282,000 13,259,000 18,207,000 16,909,000 15,515,000 20,736,000 19,572,000 13,672,000 9,951,000 7,907,000 6,553,000 3,970,000 4,414,000 11,960,000 274,548,000 1,472,000 
          impairments
        		                    
          loss from equity method investments
        		33,052,000 -13,133,000 -5,412,000 -12,672,000 2,694,000 -2,047,000 -9,955,000 -5,684,000 8,018,000   -1,376,000 -7,247,000 4,314,000 -5,754,000 -2,033,000 8,846,000 452,000   
          distributions of earnings from equity method investments
        		    0 0               
          gain and adjustments on sales of assets
        		                    
          other
        		                    
          changes in operating assets and liabilities:
        		   -38,794,000  92,136,000 -3,977,000 -63,335,000             
          receivables
        		                    
          prepaid expense and other current assets
        		                    
          other assets
        		                    
          medical claims and related payables
        		                    
          accounts payable and accrued expenses
        		                    
          other liabilities
        		                    
          net cash from operating activities
        		-20,537,000 -18,154,000 -35,085,000 -31,987,000 16,419,000 -7,703,000 -18,717,000 -47,776,000 -61,166,000 -13,018,000 -21,204,000 -60,811,000 -49,959,000 2,647,000 -60,263,000 -23,233,000 -48,897,000 -19,143,000 -39,291,000 -40,828,000 
          capital expenditures
        		-2,968,000 -3,175,000 -3,250,000 -3,849,000 -3,266,000 -3,534,000 -3,312,000 -3,139,000 -3,932,000 -4,087,000 -4,094,000 -3,717,000 -3,489,000 -3,433,000 -4,455,000 -4,049,000 -3,400,000 -2,518,000 -468,000 -178,000 
          free cash flows
        		-23,505,000 -21,329,000 -38,335,000 -35,836,000 13,153,000 -11,237,000 -22,029,000 -50,915,000 -65,098,000 -17,105,000 -25,298,000 -64,528,000 -53,448,000 -786,000 -64,718,000 -27,282,000 -52,297,000 -21,661,000 -39,759,000 -41,006,000 
          cash flows from investing activities:
        		                    
          purchase of property and equipment
        		-2,968,000 -3,175,000 -3,250,000 -3,849,000 -3,266,000 -3,534,000 -3,312,000 -3,139,000 -3,932,000 -4,087,000 -4,094,000 -3,717,000 -3,489,000 -3,433,000 -4,455,000 -4,049,000 -3,400,000 -2,518,000 -468,000 -178,000 
          purchase of intangible assets
        		-6,790,000 -13,359,000 -2,683,000 -7,034,000 -9,157,000 -984,000 -6,455,000 -11,438,000 -11,450,000 -1,698,000   -4,820,000 -247,000 -11,168,000 -1,000,000 -68,000 -2,776,000 -32,000 -3,986,000 
          investments in loans receivable and other
        		                    
          investments in marketable securities
        		0 0 -12,637,000 -47,517,000 0 0   -7,637,000 -41,452,000 -35,599,000 -29,969,000 -35,082,000 -138,106,000       
          proceeds from maturities of marketable securities and other
        		33,341,000 35,192,000 90,028,000 35,311,000  51,081,000 41,224,000 74,523,000             
          net cash paid in business combination
        		        -773,000 -112,000 0 -44,367,000         
          proceeds from sale of business and property, net of cash divested
        		            0 0 0 500,000 1,300,000 0   
          net cash from investing activities
        		22,583,000 18,658,000 70,458,000 -23,089,000 23,673,000 46,563,000 18,217,000 51,438,000 -2,203,000 -11,034,000 20,032,000 -50,814,000 -7,970,000 -130,938,000 -296,611,000 -8,869,000 -2,603,000 -11,565,000 -67,264,000 -9,074,000 
          cash flows from financing activities:
        		                    
          proceeds from (payments for) equity issuances
        		-17,000 -236,000                   
          common stock repurchase
        		        0 0           
          repayments of long-term debt
        		    0 -1,250,000 -1,250,000 -1,250,000  -1,250,000 -1,250,000 -1,250,000  -1,250,000 -1,250,000 -1,250,000     
          net cash from financing activities
        		-17,000 -236,000 -2,580,000 -161,000 -22,000 -1,406,000 -1,714,000 559,000 -845,000 1,410,000 -202,037,000 8,339,000 1,130,000 9,111,000 4,309,000 13,506,000 10,417,000 896,000 1,112,779,000 30,298,000 
          net increase in cash, cash equivalents and restricted cash and equivalents
        		2,029,000 268,000 32,793,000 -55,237,000 40,070,000 37,454,000 -2,214,000 4,221,000 -64,214,000 -22,642,000 -203,209,000 -103,286,000 -56,799,000 -119,180,000 -352,565,000 -18,596,000 -41,083,000 -29,812,000 1,006,224,000 -19,604,000 
          cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of year
        		                    
          cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of year
        		                    
          cash, cash equivalents and restricted cash and equivalents, beginning of year
        		                    
          cash, cash equivalents and restricted cash and equivalents, end of year
        		                    
          adjustments on sale of assets
        		 0 0 -14,000,000                 
          other noncash items
        		 -2,464,000 -878,000 -2,229,000  346,000 -365,000 -472,000  811,000 -537,000 -1,785,000  764,000 2,941,000 556,000  -2,122,000 245,000 1,766,000 
          investment in loans receivable and other
        		 0    0    -310,000 -7,167,000 -1,301,000  0 -7,000 -4,503,000  -6,306,000 -69,103,000 -1,204,000 
          cash, cash equivalents and restricted cash and equivalents, beginning of period
        		 0 0 193,860,000  0 0 114,329,000  0 0 507,680,000  0 0 1,054,820,000  0 0 139,095,000 
          cash, cash equivalents and restricted cash and equivalents, end of period
        		 268,000 32,793,000 138,623,000  37,454,000 -2,214,000 118,550,000  -22,642,000 -203,209,000 404,394,000  -119,180,000 -352,565,000 1,036,224,000  -29,812,000 1,006,224,000 119,491,000 
          changes in operating assets and liabilities
        		         6,267,000 -20,487,000 -91,470,000  16,951,000 -46,314,000 -30,254,000  2,588,000 -16,629,000 -33,582,000 
          proceeds from equity issuances
        		   -161,000 -22,000 -156,000 -464,000 1,809,000  2,660,000 -787,000 9,589,000         
          adjustments to reconcile net loss to net cash from operating activities:
        		                    
          deferred income taxes and uncertain tax positions
        		                    
          release of indemnification assets
        		                    
          loss on sale of assets
        		    0   4,996,000             
          other non-cash items
        		                    
          proceeds from maturities and sales of marketable securities and other
        		        30,146,000 36,625,000 68,729,000 28,540,000         
          cash, cash equivalents and restricted cash and equivalents from continuing operations, end of year
        		                    
          cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of year
        		                    
          cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period
        		     0 0 114,329,000      0 0 1,054,820,000  0 0 135,178,000 
          cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period
        		                 0 0 3,917,000 
          cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period
        		     37,454,000 -2,214,000 118,550,000          -29,812,000 1,006,224,000 119,491,000 
          cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period
        		                    
          loss on sale of assets, net and impairments
        		                    
          funding of loans receivable and other
        		       -8,508,000             
          loss on debt extinguishment
        		                0 0 404,000 1,186,000 
          proceeds from initial public offering
        		                0 0   
          proceeds from other equity issuances
        		            2,380,000 10,361,000       
          proceeds from the issuance of long-term debt
        		                0 0 0 100,000,000 
          repayments of long-term borrowings and other
        		                -1,252,000 1,000   
          equity and debt issuance costs and other
        		                -4,811,000 -160,000   
          loss (income) from equity method investments
        		                    
          repurchase of shares
        		                    
          proceeds from sale of marketable securities and other
        		                    
          proceeds from repayment of loans receivable and other
        		              4,096,000 183,000     
          proceeds from exercise of stock options
        		               14,756,000 16,480,000 1,055,000 386,000 165,000 
          debt issuance costs
        		                   -1,218,000 
          distribution to noncontrolling interests
        		                    
          proceeds from repayment of loans receivable
        		                 35,000   
          proceeds from sale of business, net of cash divested
        		                   -3,706,000 
          repayments of long-term borrowings
        		                   -68,649,000